Belgium· BE-AMP-SAM312706-00
Foscan 1 mg/ml
A temoporfin product containing temoporfin, registered in Belgium by Biolitec Pharma. The same ATC class is registered in 8 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Temoporfin is registered in 8 of 19 countries.
Countries holding a registration under ATC L01XD05 (temoporfin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 5 of them publish a price we can compare per daily dose
Temoporfin · ATC L01XD05
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Polandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Temoporfin
- Manufacturer
- Biolitec Pharma
- Country
- Belgium (BE)
- ATC code
- L01XD05
- ATC class
- Temoporfin
- Defined daily dose
- 10.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Temoporfin in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFOSCANbiolitec Pharma Ltd., Jena
- SpainFOSCAN 1 mg/ml SOLUCION INYECTABLEBiolitec Pharma Limited
- IcelandFoscanBiolitec Pharma Ltd.
- PolandFoscanbiolitec Pharma Ltd.
- SwedenFoscan 1 mg/ml Injektionsvätska, lösningBiolitec Pharma Ltd
- United KingdomFoscan 1mg/1ml solution for injection vialsBiolitec Pharma Ltd
- FinlandFoscanBiolitec Pharma Ltd. Unit 9 A
- NetherlandsFoscan 1 mg/ml, oplossing voor injectieBiolitec Pharma
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a8054ff1-75b2-468d-9eaf-021a91d1de4b GET /v1/drugs/a8054ff1-75b2-468d-9eaf-021a91d1de4b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Foscan 1 mg/ml",
"name_fr": "Foscan 1 mg/ml",
"name_nl": "Foscan 1 mg/ml",
"amp_code": "SAM312706-00",
"strengths": [
"1.0000",
"376.0000",
"560.0000"
],
"pack_count": 1,
"substances": [
"Temoporfin",
"Anhydrous Ethanol",
"Propylene Glycol"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Temoporfin",
"authorisation_numbers": [
"EU/1/01/197/003"
]
}See everything about temoporfin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.